Matches 1 - 50 out of 148 1 2 3 >
Match Document Document Title
7488756 Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds  
This invention relates to the use of chemical compounds showing non-competitive and selective GluR5 antagonist or partial agonist activity for treating diseases that are responsive to modulation of...
7465754 Method of potentiating chemotherapy and treating solid tumors  
This invention provides a method of treating solid tumors which comprises administering an effective amount of a combination of (1) a bioresponse modifier and (2) a chemotherapeutic agent. This...
7384979 Substituted amino acids as erythropoietin mimetics  
This invention relates to a series of substitituted amino acids of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the...
7378102 Diclofenac sodium oral pharmaceutical  
The present invention relates to a diclofenac sodium oral pharmaceutical containing diclofenac sodium, a nonionic surfactant, a cholic acid derivative as an absorption promoting agent, and a...
7323187 Impregnation method  
The invention relates to a method for impregnating, incorporating or surface-treating substances/articles that can be microbially decomposed, contaminated and/or infested with parasites and/or that...
7321000 Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome  
An ophthalmic pharmaceutical composition containing acetylcysteine as the active ingredient having a mucolitic action, suitable for administration in eyedrops, where N-acetyl-cysteine is...
7318930 Control methods for boring bark beetles  
A composition which causes adult boring bark beetles to discontinue boring, discontinue laying eggs and become disoriented and bore out of the tree or cease boring altogether and die is described....
7291596 Pharmaceutical composition for thrombin peptide derivatives  
Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical...
7238661 Oral lactoferrin in the treatment of respiratory disorders  
The present invention relates to methods of treating an allergic or non-allergic respiratory disorder by administering orally a composition of lactoferrin alone or in combination with metal...
7176239 Methods and compositions for treatment of Ataxia-telangeictasia  
This invention relates to the methods and pharmaceutical compositions for treating diseases or disorders associated with oxidative stress and/or genomic instability. In particular, the invention...
7056950 Compositions of biochemical compounds involved in bioenergy metabolism of cells  
A composition of biochemical compounds involved in bioenergy metabolism of cells and a method of use in prevention and therapy of diseases are disclosed.
7012096 Composition for pain mediation and apparatus and method of use thereof  
The present invention is directed to a composition for treating burns. The composition comprises a therapeutically effective amount of one or more weak organic acid compatible with human skin, in a...
6984661 Urea linker derivatives for use as PPAR modulators  
The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each...
6875764 Urea and thiourea compounds useful for treatment of coccidiosis  
The present invention relates to novel compounds, pharmaceutical compositions containing the same as well as a method for treatment of parasitic disorders, wherein said compounds are administered....
6824794 Method and apparatus for preventing bacteria and algae growth in water  
A water treatment agent and method of treating water to inhibit, reduce, or prevent the formation of algae and bacteria in a water body. The water treatment agent may include copper sulfate...
6793914 Anti-microbial compositions  
An anti-microbial composition employing: (i) a C 1 to C 4 monohydric alcohol carrier fluid, present at a level of at least 50% by weight of the total composition (excluding any volatile...
6784209 Food supplement for increasing lean mass and strength  
Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described...
6777436 Intraocular tension lowering compositions for topical administration  
An intraocular tension lowering composition for topical administration is disclosed which comprises an effective amount of an (i) angiotensin II antagonist, (ii) a boric aid and (iii) an...
6720356 Magnesium di-potassium EDTA complex and method of administration  
A composition containing an EDTA complex in the form of a suppository is provided. More specifically, the EDTA complex is a magnesium di-potassium EDTA complex. The suppository may contain a...
6670397 Methods for transdifferentiation of body tissues  
This invention relates to methods for transdifferentiation of body tissues which can be used to generate specific cell types needed for regenerating organs or body parts, following cellular...
6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof  
The present invention provides compositions and methods for treating an animal, preferably a human, suffering from or predisposed to a physical disorder by administering an effective amount of a...
6599940 Synthesis of 2-hydroxymethylglutamic acid and congeners thereof  
One aspect of the present invention relates to 2-hydroxymethylglutamic acid and congeners thereof. A second aspect of the invention relates to a method of synthesizing 2-hydroxymethylglutamic acid...
6596752 Inhibitors of α4β1 mediated cell adhesion  
The present invention relates to small molecules according to the formula [I]: which are potent inhibitors of α 4 β 1 mediated adhesion to either VCAM or CS-1 and which can be used for...
6537590 Solution and the method of making the same for the treatment of osteoarthritis  
A solution and the method of making the same for the treatment of osteoarthritis for treating symptoms of osteoarthritic conditions. The solution and the method of making the same for the treatment...
6534543 Oxa acids and related compounds for treating skin conditions  
The present invention is directed to the use of compounds of Formula (I), as active principals for treating skin conditions and compositions containing these compounds wherein R 4 is (CR 5 R 6...
6531510 N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid in iron chelating therapy  
The use of a novel mono-cationic salt of N,N′-bis(2-hydroxybenzyl) ethylenediamine-N,N′-diacetic acid (HBED) in iron chelating therapy is disclosed. In particular, the invention relates to the...
6497892 Cosmetic and skin protective compositions  
A hair and scalp formulation based on a peroxidase enzyme and synergistic yeast extract therefore. It entails a chemically-inert carrier material, a germicidal/preservative agent, and a metal...
6479528 Methods for inhibiting or reversing tau filament formation polymerization  
Methods for inhibiting and/or reversing tau filament formation or polymerization are provided. These methods can be used for treating certain neurological disorders in vivo by administering...
6469056 Pharmaceutically active compounds, their preparation and use as ECE-inhibitors  
Pharmaceutically active compounds are prepared as described and used to produce pharmaceutical preparations for treating diseases.
6468987 Nutritional product for a person having ulcerative colitis  
An enteral nutritional product for a person having ulcerative colitis contains in combination (a) an oil blend which contains eicosapentaenoic acid (20:5n3) and/or docosahexaenoic acid (22:6n3),...
6468965 Pharmaceutical composition for oral administration of a mixture of chelating agents  
A solid pharmaceutical composition for the oral administration of chelating agents to an individual consists essentially of: at least 100 milligrams of ethylenediamninctetraacetic acid (EDTA) or a...
6429225 Chelate compound-containing antibacterial agent for Helicobacter pylori  
An antibacterial agent is provided, which has an action for inhibiting growth of Helicobacter pylori participating to occurrence of chronic gastritis and gastric ulcer, and a highly safe...
6423348 Anticoagulant compositions  
What is shown is an animal blood anticoagulant compound useful in the meat packing industry generally, and in slaughterhouse operations, particularly. The anticoagulant is effective when diluted...
6352706 Naturally occurring enhancer of metal toxicants in molluscs  
An ingestible mollusc poison contains a simple metal compound, an activity enhancing additive such as ethylene diamine disuccinic acid (EDDS) and derivatives thereof, and a carrier material edible...
6342243 Method of fattening up a ruminant  
An amino acid and/or a peptide are orally administrated to a neonatal ruminant whose fermenting function of the rumen has not yet developed thereby effecting a significant increase in the...
6331505 Method for increasing plant productivity using glutamic acid and glycolic acid  
Compositions including glutamic acid and either glycolic acid or polyglycolic acid, salts of these compounds or combinations thereof are described as are such compositions that include a calcium...
6310083 Caged amino acid derivatives bearing photolabile protective groups  
Derivatives of o-nitromandelyoxycarbonyl (Nmoc) which are capable of releasing an amino acid (or derivative thereof), upon irradiation with ultraviolet (UV) light are disclosed, as well as a method...
6274625 Anti-microbial compound  
There is provided use of an amino acid derivative in free acid or salt form, in which the nitrogen atoms of two or more amino acid molecules are linked by a hydrocarbyl or substituted hydrocarbyl...
6245803 Palatable elemental medical food  
This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific...
6239166 Compositions for killing dust mites and methods of using same  
The invention relates to an aqueous pesticide composition for killing dust mites, which contains a chelating agent as the active ingredient and a surfactant to facilitate distribution over, or...
6140374 Propofol composition  
The present invention is directed to a sterile pharmaceutical composition comprising a propofol containing oil-in-water emulsion formulation having as an antimicrobial agent, a member selected from...
6140367 Use of ethylene diamine disuccinate for preparing a medicament with antiviral properties  
Use of (S,S)-N,N'-ethylenediamine disuccinate (EDDS) of formula I wherein MH + and/or any pharmaceutically acceptable cation, for the preparation of a medicament for the treatment of...
6124361 Bicyclo[3.1.0]hexanes and related compounds  
The present invention relates to compounds of the formula I, as defined in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological...
6114387 Pharmaceutical composition for oral administration of chelating agents  
A solid pharmaceutical composition for the oral administration of chelating agents to an individual consists essentially of: at least 100 milligrams of ethylenediaminetetraacetic acid (EDTA) or a...
6107342 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for the preparation thereof  
The present invention relates to the compound of formulae ##STR1## and to a process for the manufacture of compounds of the general formula ##STR2## which are ligands for the metabotropic glutamate...
6083498 Chemical attractants for yellowjackets and paper wasps  
Compositions and lures are described which provide vapor blends of acetic acid and one or more compounds selected from the group consisting of isobutanol, racemic 2-methyl-1-butanol,...
6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor  
The use of a combination of an alpha RAR receptor-specific agonist ligand and a gamma RAR receptor-specific antagonist ligand to reduce the rate of apoptosis is disclosed.
6051605 Method of treating psychosis and schizophrenia  
This invention relates to compounds that are antagonists of dopamine D4 receptors, and to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4...
6015828 Chemical modification of chloride channels as a treatment for cystic fibrosis and other diseases  
This invention relates generally to medical treatment methods. Specifically, the invention relates to methodology for the correction of defective chloride transport by activation of chloride...
6015792 Specific eatable taste modifiers  
Ingestible compounds which are substantially tasteless and which have been found to be effective reducers or eliminators of undesirable tastes for eatables.
Matches 1 - 50 out of 148 1 2 3 >